Cargando…
Tapinarof for the treatment of psoriasis
Although topical drugs are the mainstay of treatment for patients with mild‐to‐moderate psoriasis, the developments observed in this field in the last two decades have been limited. The most commonly used drugs are still vitamin D analogues and corticosteroids, both with several limitations. The ary...
Autores principales: | Nogueira, Sofia, Rodrigues, Maria Alexandra, Vender, Ron, Torres, Tiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078538/ https://www.ncbi.nlm.nih.gov/pubmed/36226669 http://dx.doi.org/10.1111/dth.15931 |
Ejemplares similares
-
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
por: Spencer, Riley K, et al.
Publicado: (2023) -
Psoriasis, biologic therapy, and the pandemic of the 21st century
por: Nogueira, Miguel, et al.
Publicado: (2020) -
Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022) -
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
por: Jett, John E., et al.
Publicado: (2021) -
Correction: Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022)